MULROY DENNIS — SEC Form 4 filings
SEC reporting owner CIK 1276840. 12 Form 4 filings on record with FilingPulse; latest filed 2026-05-07.
Transaction summary — filings shown
Covers all 12 filings on record, filed 2024-01-09 to 2026-05-07. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 11 legs across 9 filings — 52,476 shares, $2,192,607 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 10,000 shares @ $50.00 ($500,000) in ANAPTYSBIO, INC, filed 2025-12-23.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| ANAPTYSBIO, INC (ANAB) | CHIEF FINANCIAL OFFICER | 11 | — | 11 legs · 52,476 sh · $2,192,607 | 27 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | Chief Financial Officer | 1 | — | — | 1 |
Form 4 filings — MULROY DENNIS
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-05-07 | 4 | Arcturus Therapeutics Holdings Inc. (ARCT) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,700 · Sale (S): 2,515 @ $44.71 · Option exercise (M): 6,700 (derivative) @ $0 | EDGAR |
| 2026-01-08 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,245 · Sale (S): 1,908 @ $45.11 · Option exercise (M): 5,245 (derivative) @ $0 · Grant/award (A): 21,400 (derivative) @ $0 · Grant/award (A): 29,000 (derivative) @ $0 | EDGAR |
| 2026-01-06 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 8,292 · Sale (S): 3,363 @ $43.26 · Option exercise (M): 8,292 (derivative) @ $0 | EDGAR |
| 2025-12-23 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $20.16 · Sale (S): 10,000 @ $50 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-12-18 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 10,000 @ $20.16 · Sale (S): 9,365 @ $44.62 · Sale (S): 6,360 @ $45.21 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2025-01-07 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 8,293 · Tax withholding (F): 3,407 @ $14.60 · Option exercise (M): 5,245 · Tax withholding (F): 2,054 @ $15.30 · Option exercise (M): 8,293 (derivative) @ $0 · Option exercise (M): 5,245 (derivative) @ $0 · +2 more | EDGAR |
| 2024-09-17 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 6,000 · Sale (S): 2,220 @ $38.93 · Option exercise (M): 10,000 @ $20.16 · Sale (S): 10,000 @ $40.13 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 10,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | ANAPTYSBIO, INC (ANAB) | Grant/award (A): 20,000 (derivative) @ $0 | EDGAR |
| 2024-05-24 | 4 | ANAPTYSBIO, INC (ANAB) | Sale (S): 1,500 @ $23.72 | EDGAR |
| 2024-02-01 | 4 | ANAPTYSBIO, INC (ANAB) | Sale (S): 3,065 @ $23.63 | EDGAR |
| 2024-01-09 | 4 | ANAPTYSBIO, INC (ANAB) | Option exercise (M): 5,245 @ $0 · Sale (S): 2,180 @ $21.81 · Option exercise (M): 5,245 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-09 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1276840 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →